8-K
Current Report
Xenon Pharmaceuticals Inc. Filed Acc 0001564590-18-016771
Material agreement · Agreement ended
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
From the SEC's structured data for this filing
Loading xene-8k_20180711.htm…